Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
GLP-1 receptor agonists are a class of drugs with high efficacy, a good safety profile recommended as second-line drugs after metformin for the treatment of type 2 diabetes mellitus. Dulaglutide is a GLP-1 analogue designed for once weekly subcutaneous injection using recombinant technology and appr...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
Remedium Group LLC
2018-03-01
|
| סדרה: | Медицинский совет |
| נושאים: | |
| גישה מקוונת: | https://www.med-sovet.pro/jour/article/view/2329 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|